17/07/2026
Join a clinical study that aims to move research – and people – forward
• Are you 18 years or older living with obesity or overweight?
• Do you also have Type 2 diabetes?
If the above relates to you, you may be able to join the KaiNETIC-2 Study. The KaiNETIC-2 Study is looking to learn more about different doses of an investigational study drug designed to help people with Type 2 diabetes lose weight, lower blood sugar levels, and improve their health.
Different doses of the study drug will be compared with a placebo. Both are together referred to as ‘study medication’. A placebo looks like the study drug but contains no active medicine. Participants will have a higher chance of receiving the study drug. The study medication will be given as a subcutaneous injection, that is under the skin. You will take it once every week. The study will last up to 84 weeks. There will be no cost for the study medication, or study-related health assessments and medical tests.
Want to get involved? Email [email protected] 📧 or call 0300 019 6686 📱
An Ethics Committee (EC) has reviewed this study. An EC protects the rights, safety, and wellbeing of study participants.